ATE473239T1 - Interleukin-9 antagonist-muteine und ihre pharmakologischen anwendungsverfahren - Google Patents

Interleukin-9 antagonist-muteine und ihre pharmakologischen anwendungsverfahren

Info

Publication number
ATE473239T1
ATE473239T1 AT04752242T AT04752242T ATE473239T1 AT E473239 T1 ATE473239 T1 AT E473239T1 AT 04752242 T AT04752242 T AT 04752242T AT 04752242 T AT04752242 T AT 04752242T AT E473239 T1 ATE473239 T1 AT E473239T1
Authority
AT
Austria
Prior art keywords
muteins
interleukin
proteins
pharmacological applications
methods
Prior art date
Application number
AT04752242T
Other languages
English (en)
Inventor
David Boisvert
Malinda Longphre
Sydney Zaremba
Armen Shanafelt
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Application granted granted Critical
Publication of ATE473239T1 publication Critical patent/ATE473239T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5425—IL-9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT04752242T 2003-05-14 2004-05-14 Interleukin-9 antagonist-muteine und ihre pharmakologischen anwendungsverfahren ATE473239T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47063003P 2003-05-14 2003-05-14
PCT/US2004/015168 WO2004103295A2 (en) 2003-05-14 2004-05-14 Interleukin-9 antagonist muteins and their pharmacological methods of use

Publications (1)

Publication Number Publication Date
ATE473239T1 true ATE473239T1 (de) 2010-07-15

Family

ID=33476726

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04752242T ATE473239T1 (de) 2003-05-14 2004-05-14 Interleukin-9 antagonist-muteine und ihre pharmakologischen anwendungsverfahren

Country Status (5)

Country Link
US (2) US7423123B2 (de)
EP (1) EP1622568B1 (de)
AT (1) ATE473239T1 (de)
DE (1) DE602004028007D1 (de)
WO (1) WO2004103295A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635754B2 (en) 2004-09-22 2009-12-22 Aerovance, Inc. Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same
CA2824515C (en) * 2011-01-18 2022-09-13 Bioniz, Llc Compositions and methods for modulating gamma-c-cytokine activity
US9629910B2 (en) 2011-03-22 2017-04-25 The Brigham And Women's Hospital, Inc. Use of Th9 cells and IL-9 for the treatment of melanoma
US11492383B2 (en) 2011-06-24 2022-11-08 Stephen D. Gillies Light chain immunoglobulin fusion proteins and methods of use thereof
US9959384B2 (en) 2013-12-10 2018-05-01 Bioniz, Llc Methods of developing selective peptide antagonists
EP3978512A1 (de) 2015-10-09 2022-04-06 Bioniz, LLC Modulation der gamma-c-zytokin-aktivität
KR102707650B1 (ko) 2017-04-07 2024-09-19 바이오니즈 테라퓨틱스, 아이엔씨. 감마-c-사이토카인 활성의 안정한 조절자
BR112021021878A2 (pt) 2019-05-03 2022-01-18 Bioniz Llc Modulação dos efeitos de sinalização da gama-c-citocina para tratamento da alopecia e distúrbios associados

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208218A (en) * 1988-09-19 1993-05-04 Ludwig Institute For Cancer Research T cell growth factor glycoproteins
US5587302A (en) * 1988-09-19 1996-12-24 Ludwig Institute For Cancer Research T cell growth factor
US5472841A (en) * 1990-06-11 1995-12-05 Nexstar Pharmaceuticals, Inc. Methods for identifying nucleic acid ligands of human neutrophil elastase
US5908839A (en) * 1995-08-24 1999-06-01 Magainin Pharmaceuticals, Inc. Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
GB9810999D0 (en) * 1998-05-21 1998-07-22 Goken Joop Materials and methods relating to the expression of genes
ATE540695T1 (de) * 2001-06-08 2012-01-15 Genaera Corp Verfahren zur modulation von il-13

Also Published As

Publication number Publication date
WO2004103295A2 (en) 2004-12-02
US20040247566A1 (en) 2004-12-09
WO2004103295A3 (en) 2007-03-15
EP1622568A4 (de) 2008-12-03
US20090148403A1 (en) 2009-06-11
US7423123B2 (en) 2008-09-09
DE602004028007D1 (de) 2010-08-19
EP1622568B1 (de) 2010-07-07
EP1622568A2 (de) 2006-02-08

Similar Documents

Publication Publication Date Title
CY1120874T1 (el) Συνθεση αντισωματος ιντερλευκινης-13
NO20051726L (no) Pyrimidinonderivaer som terapeutiske midler ovenfor akutte og kroniske inflammasjons-, iskemiske og remodeleringsprosesser
NO20064976L (no) Azanidoler som er nyttige som inhibitorer av rock og andre proteinkinaser
ATE464303T1 (de) Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen
EP1485381B8 (de) Azolylaminoazine als inhibitoren von proteinkinasen
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
SG151327A1 (en) Deazapurines useful as inhibitors of janus kinases
NO20060424L (no) 5-heteroringbaserte P38 kinaseinhibitorer
CA2525437A1 (en) Benzamide inhibitors of the p2x7 receptor
AU2003220299A1 (en) Azinylaminoazoles as inhibitors of protein kinases
AU2003218215A1 (en) Azolylaminoazines as inhibitors of protein kinases
ATE457313T1 (de) Bicyclische heterocyclische p-38-kinase- inhibitoren
MXPA06011327A (es) Azaindoles utiles como inhibidores de jak y otras proteinas cinasas.
WO2005028475A3 (en) Compositions useful as inhibitors of protein kinases
DK1448564T3 (da) Substituerede indolizinlignende forbindelser og fremgangsmåder til anvendelse
NO20082508L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
TW200510416A (en) P38 inhibitors and methods of use thereof
NO20083501L (no) Azaindoler som er anvendelige som inhibitorer for Janus-kinaser
MX2009010127A (es) Compuestos utiles como inhibidores de janus cinasas.
NO20070994L (no) N-hydroksamid derivater og anvendelse derav
NO20065727L (no) Pyrrolinhibitorer av erk-proteinkinase, syntese derav og deres mellomprodukter
EA200802020A1 (ru) Тетрагидропиримидоазепины и их применение в качестве модуляторов trpv 1
IS8175A (is) Píperasín afleiður og aðferðir við notkun þeirra
WO2009015063A3 (en) Methods and compositions for treating fibrosis related disorders using il-17 antagonists
DE602004028007D1 (de) Interleukin-9 antagonist-muteine und ihre pharmakologischen anwendungsverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties